Hypertension Management Goals by Age
For most adults, the blood pressure target should be <130/80 mmHg regardless of age, with specific modifications based on comorbidities rather than age alone. 1
General Adult Population (<60 years)
- Target BP: <130/80 mmHg for adults under 60 years of age with hypertension 1
- This target applies to most patients without specific comorbidities and is supported by meta-analyses showing significant reductions in major cardiovascular events, stroke, heart failure, and myocardial infarction with lower BP targets 1
- The 2017 ACC/AHA guideline represents the most current evidence-based approach, superseding older recommendations that used <140/90 mmHg as the general target 1
Adults Aged 60-79 Years
- Target BP: <130/80 mmHg for community-dwelling adults aged 60-79 years who are ambulatory and non-institutionalized 1
- This recommendation is based on evidence showing that patients ≥60 years achieved similar cardiovascular benefits with lower BP targets as younger populations, with significant reductions in major cardiovascular events, stroke, and heart failure 1
- Controversial alternative: Some guidelines (JNC-8, ACP/AAFP) recommend a less aggressive target of <150/90 mmHg for adults ≥60 years, but this represents older evidence and has been debated extensively in the literature 1
Adults Aged ≥80 Years
- Target BP: <130/80 mmHg for fit, community-dwelling adults ≥80 years with preserved functional status 1
- The SPRINT and HYVET trials demonstrated substantial cardiovascular benefits in adults over 80 years, including those who were frail but living independently in the community 1
- Critical caveat: Initiation of BP-lowering therapy should be done cautiously with careful monitoring for orthostatic hypotension and adverse effects 1
- For institutionalized or severely frail elderly with significant loss of activities of daily living, treatment goals require individualized assessment with consideration of deprescribing when appropriate 2
Patients with Diabetes Mellitus (All Ages)
- Target BP: <130/80 mmHg for all adults with diabetes and hypertension 1
- Most adults with diabetes and hypertension automatically qualify as high cardiovascular risk (≥10% 10-year ASCVD risk), warranting initiation of drug therapy at BP ≥130/80 mmHg 1
- Meta-analyses including ACCORD and SPRINT data support this lower target, showing consistent cardiovascular benefits in diabetic patients 1
- Older guidelines (JNC-7, ESH/ESC 2007) also recommended <130/80 mmHg for diabetic patients, with some evidence supporting even lower targets (<125/75 mmHg) for those with significant proteinuria 1
Patients with Chronic Kidney Disease (All Ages)
- Target BP: <130/80 mmHg for all adults with CKD and hypertension 1
- Patients with CKD are automatically classified as high cardiovascular risk, warranting aggressive BP control 1
- SPRINT provided strong evidence supporting this target, showing cardiovascular benefits in patients with CKD 1
- With proteinuria: Some guidelines suggest even more aggressive control (<125/75 mmHg) when significant proteinuria is present, as this reduces progression of renal disease 1
- ACE inhibitors or ARBs are preferred first-line agents in CKD patients due to renoprotective effects 1
Patients with Established Cardiovascular Disease (All Ages)
- Target BP: <130/80 mmHg for patients with history of stroke, myocardial infarction, heart failure, or other cardiovascular disease 1
- These patients are at very high cardiovascular risk and benefit from intensive BP lowering 1
- The 2017 ACC/AHA Heart Failure Focused Update specifically recommends <130/80 mmHg for patients at increased risk of developing cardiovascular disease 1
Key Implementation Principles
- Measurement accuracy is critical: Proper technique requires 5 minutes of rest, seated position with back supported, feet flat on floor, arm supported at heart level, appropriate cuff size on bare arm, and no talking during measurement 3
- Confirm diagnosis: Hypertension diagnosis requires average of ≥2 readings on ≥2 separate occasions, with out-of-office monitoring (home or ambulatory) strongly recommended to exclude white coat hypertension 3
- Staged approach for older adults: When initiating therapy in adults ≥65 years, start cautiously and monitor closely for adverse effects including orthostatic hypotension, syncope, electrolyte abnormalities, and acute kidney injury 1
- Systolic BP priority: For patients ≥50 years, achieving systolic BP goal is the primary focus, as most will reach diastolic goal once systolic target is achieved 1
- Lifestyle modifications: All patients should receive lifestyle interventions including sodium restriction (<1500 mg/day ideal), weight loss if overweight, DASH diet, regular physical activity, and alcohol moderation, as these enhance medication efficacy 1, 4